Antiemetic action of 5-HT3 receptor antagonists: review of preclinical and clinical results with ICS 205–930

This publication has 14 references indexed in Scilit:

• 5‐HT₃ receptor antagonists injected into the area postrema inhibit cisplatin‐induced emesis in the ferret
  British Journal of Pharmacology, 1989
• Blockade of 5-Hydroxytryptamine3 receptors prevents cisplatin-induced but not motion- or xylazine-induced emesis in the cat
  Pharmacology Biochemistry and Behavior, 1989
• The anti-emetic potential of the 5-hydroxytryptamine3 receptor antagonist BRL 43694
  British Journal of Cancer, 1988
• Neuropharmacology of emesis induced by anti-cancer therapy
  Trends in Pharmacological Sciences, 1988
• THE ROLE OF THE ABDOMINAL VISCERAL INNERVATION AND 5‐HYDROXYTRYPTAMINE M‐RECEPTORS IN VOMITING INDUCED BY THE CYTOTOXIC DRUGS CYCLOPHOSPHAMIDE AND CIS‐PLATIN IN THE FERRET
  Quarterly Journal of Experimental Physiology, 1988
• Evidence that 5-hydroxytryptamine3 receptors mediate cytotoxic drug and radiation-evoked emesis
  British Journal of Cancer, 1987
• FIRST RESULTS WITH ICS 205-930 (5-HT3 RECEPTOR ANTAGONIST) IN PREVENTION OF CHEMOTHERAPY-INDUCED EMESIS
  The Lancet, 1987
• 5-HT3 receptors and cytotoxic drug-induced vomiting
  Trends in Pharmacological Sciences, 1987
• 5-hydroxytryptamine m-receptor antagonism to prevent cisplatin-induced emesis
  Neuropharmacology, 1986
• Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs
  Nature, 1985